AXIM Biotechnologies expands advisory board
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
The board of AXIM Biotechnologies Inc. appointed Ilya Reznik to the company's advisory board on Dec. 7, according to a Form 8-K filing.
Reznik is a board-certified specialist in adult forensic and clinical neuropsychiatry in Israel.
